Amphotericin B in vitro resistance is associated with fatal Aspergillus flavus infection

Medical Mycology

Volumn 87, Issue 8, 2012, Pages 829-834

  Hadrich, Inès ^a   Makni, Fattouma ^a   Neji, Sourour ^a   Cheikhrouhou, Fatma ^a   Bellaaj, Hatem ^b   Elloumi, Moez ^b   Ayadi, Ali ^a   Ranque, Stéphane ^c  

^a UNIVERSITY OF SFAX   (Tunisia)

^b HEDI CHAKER HOSPITAL   (Tunisia)

^c AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Amphotericin B; Aspergillus flavus; Etest; Haematological malignancies; Outcome

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; ITRACONAZOLE; POSACONAZOLE; VORICONAZOLE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; APLASIA; ARTICLE; ASPERGILLUS FLAVUS; CAUSE OF DEATH; CLINICAL ARTICLE; COHORT ANALYSIS; DRUG DOSE ESCALATION; EPSILOMETER TEST; FEMALE; FUNGUS ISOLATION; GENETIC VARIABILITY; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNOCOMPROMISED PATIENT; IN VITRO STUDY; INVASIVE ASPERGILLOSIS; MALE; MEDULLAR APLASIA; MINIMUM INHIBITORY CONCENTRATION; MONOTHERAPY; MORTALITY; MYELOID LEUKEMIA; NEUTROPENIA; PREDICTIVE VALUE; SURVIVAL RATE; TREATMENT OUTCOME; TUNISIA; ASPERGILLOSIS; DRUG DOSE INCREASE; NONHUMAN;

ADOLESCENT; ADULT; AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASPERGILLUS FLAVUS; COHORT STUDIES; DRUG RESISTANCE, FUNGAL; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; INVASIVE PULMONARY ASPERGILLOSIS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

ASPERGILLUS FLAVUS;

EID: 84867554258     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693786.2012.684154     Document Type: Article

References (24)

1. Pfaller MA, Sheehan DJ, Rex JH. Determination of fungicidal activities against yeasts and molds: lessons learned from bactericidal testing and the need for standardization. Clin Microbiol Rev 2004; 17 : 268-280. (Pubitemid 38534030)
2. Lass-Florl C, Perkhofer S. In vitro susceptibility-testing in A spergillus species. Mycoses 2008; 51 : 437-446.
3. Lass-Florl C, Kofl er G, Kropshofer G, et a l In vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis. J Antimicrob Chemother 1998; 42 : 497-502. (Pubitemid 28473010)
4. Johnson EM, Oakley KL, Radford SA, et al Lack of correlation of in vitro amphotericin B susceptibility testing with outcome in a murine model of Aspergillus infection. J Antimicrob Chemother 2000; 45 : 85-93. (Pubitemid 30060238)
5. Lionakis MS, Lewis RE, Chamilos G, Kontoyiannis DP. A spergillus susceptibility testing in patients with cancer and invasive aspergillosis: diffi culties in establishing correlation between in vitro susceptibility data and the outcome of initial amphotericin B therapy. Pharmacotherapy 2005; 25 : 1174-1180. (Pubitemid 41242577)
6. Hadrich I, Makni F, Sellami H, et al Invasive aspergillosis: epidemiology and environmental study in haematology patients (Sfax, Tunisia). Mycoses 2010; 53 : 443-447.
7. Hadrich I, Mary C, Makni F, et al Comparison of PCR-ELISA and Real-Time PCR for invasive aspergillosis diagnosis in patients with hematological malignancies. Med Mycol 2011; 49 : 489-494.
8. Hadrich I, Makni F, Ayadi A, Ranque S. Microsatellite typing to trace Aspergillus fl avus infections in a hematology unit. J Clin Microbiol 2010; 48 : 2396-2401.
9. De Pauw B, Walsh TJ, Donnelly JP, et a l Revised defi nitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46 : 1813-1821.
10. Weir BS, Hill WG. Estimating F-statistics. Annu Rev Genet 2002; 36 : 721-750. (Pubitemid 36109203)
11. Goudet J, Raymond M, de Meeus T, Rousset F. Testing differentiation in diploid populations. Genetics 1996; 144 : 1933-1940. (Pubitemid 26427937)
12. Hedayati MT, Pasqualotto AC, Warn PA, Bowyer P, Denning DW. Aspergillus fl avus : human pathogen, allergen and mycotoxin producer. Microbiology 2007; 153 : 1677-1692. (Pubitemid 46952500)
13. Van Der Linden JW, Warris A, Verweij PE. Aspergillus species intrinsically resistant to antifungal agents. Med Mycol 2011; 49 (Suppl. 1): S82-89.
14. Chamilos G, Kontoyiannis DP. Update on antifungal drug resistance mechanisms of Aspergillus fumigatus Drug Resist Updat 2005; 8 : 344-358. (Pubitemid 43358058)
15. Rex JH, Pfaller MA. Has antifungal susceptibility testing come of age? Clin Infect Dis 2002; 35 : 982-989. (Pubitemid 35178316)
16. Clancy CJ, Nguyen MH. Correlation between in vitro susceptibility determined by E test and response to therapy with amphotericin B: results from a multicenter prospective study of candidemia. Antimicrob Agents Chemother 1999; 43 : 1289-1290. (Pubitemid 29214766)
17. Bowden R, Chandrasekar P, White MH, et a l A double-blind, randomized, controlled trial of amphotericin B colloidal dispersion versus amphotericin B for treatment of invasive aspergillosis in immunocompromised patients. Clin Infect Dis 2002; 35 : 359-366. (Pubitemid 34852563)
18. Peyron F, Favel A, Michel-Nguyen A, et al Improved detection of amphotericin B-resistant isolates of Candida lusitaniae by Etest. J Clin Microbiol 2001; 39 : 339-342. (Pubitemid 32059615)
19. Nguyen MH, Clancy CJ, Yu VL, et a l Do in vitro susceptibility data predict the microbiologic response to amphotericin B? Results of a prospective study of patients with Candida fungemia. J Infect Dis 1998; 177 : 425-430. (Pubitemid 28063769)
20. Baddley JW, Marr KA, Andes DR, et al Patterns of susceptibility of Aspergillus isolates recovered from patients enrolled in the Transplant- Associated Infection Surveillance Network. J Clin Microbiol 2009; 47 : 3271-3275.
21. Bueid A, Howard SJ, Moore CB, et a l Azole antifungal resistance in Aspergillus fumigatus : 2008 and 2009. J Antimicrob Chemother 2010; 65 : 2116-2118.
22. Lortholary O, Gangneux JP, Sitbon K, et al Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005-2007). Clin Microbiol Infect 2011; 17 : 1882-1889.
23. Mortensen KL, Mellado E, Lass-Florl C, et a l Environmental study of azole-resistant Aspergillus fumigatus and other aspergilli in Austria, Denmark, and Spain. Antimicrob Agents Chemother 2010; 54 : 4545-4549.
24. Hope WW, Walsh TJ, Denning DW. Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis 2005; 5 : 609-622. (Pubitemid 41383906)